Supporting Table 3 from A Distinct Metabolic Signature of Human Colorectal Cancer with Prognostic Potential

Yunping Qiu,Guoxiang Cai,Bingsen Zhou,Dan Li,Aihua Zhao,Gary Xie,Houkai Li,Sanjun Cai,Dong Xie,Changzhi Huang,Weiting Ge,Zhanxiang Zhou,Lisa X. Xu,Jia Wang,Shusen Zheng,Yun Yen

DOI: https://doi.org/10.1158/1078-0432.22449215

2023-01-01

Abstract:PDF file 50K, Treatment information for stage II and stage III patients in Shanghai cohort

What problem does this paper attempt to address?

Supporting Table 1 from A Distinct Metabolic Signature of Human Colorectal Cancer with Prognostic Potential

Yunping Qiu,Guoxiang Cai,Bingsen Zhou,Dan Li,Aihua Zhao,Guoxiang Xie,Houkai Li,Sanjun Cai,Dong Xie,Changzhi Huang,Weiting Ge,Zhanxiang Zhou,Lisa X. Xu,Weiping Jia,Shu Zheng,Yun Yen,Wei Jia

DOI: https://doi.org/10.1158/1078-0432.22449221

2023-01-01

Abstract:PDF file 63K, VIP values from OPLS-DA models and p values in the samples the Hangzhou, Beijing and City of Hope cohorts
Supplementary Information from A Distinct Metabolic Signature of Human Colorectal Cancer with Prognostic Potential

Yunping Qiu,Guoxiang Cai,Bingsen Zhou,Dan Li,Aihua Zhao,Gary Xie,Houkai Li,Sanjun Cai,Dong Xie,Changzhi Huang,Weiting Ge,Zhanxiang Zhou,Lisa X. Xu,Jia Wang,Shusen Zheng,Yun Yen

DOI: https://doi.org/10.1158/1078-0432.22449236.v1

2023-01-01

Abstract:PDF file 119K, This file includes supplementary text and figure legends for supporting figures
Supporting Figure 2 from A Distinct Metabolic Signature of Human Colorectal Cancer with Prognostic Potential

Yunping Qiu,Guoxiang Cai,Bingsen Zhou,Dan Li,Aihua Zhao,Guoxiang Xie,Houkai Li,Sanjun Cai,Dong Xie,Changzhi Huang,Weiting Ge,Zhanxiang Zhou,Lisa X. Xu,Weiping Jia,Shu Zheng,Yun Yen,Wei Jia

DOI: https://doi.org/10.1158/1078-0432.22449230

2023-01-01

Abstract:PDF file 126K, PCA and OPLS-DA scores plot for CRC samples and adjacent non-tumor tissues collected from Hangzhou, Beijing and City of Hope
Supplementary Table S3 from A 5-Hydroxymethylcytosine-Based Noninvasive Model for Early Detection of Colorectal Carcinomas and Advanced Adenomas: The METHOD-2 Study

Wenju Chang,Zhou Zhang,Baoqing Jia,Kefeng Ding,Zhizhong Pan,Guoqiang Su,Wei Zhang,Tianyu Liu,Yunshi Zhong,Guodong He,Li Ren,Ye Wei,Dongdong Li,Xiaolong Cui,Jun Yang,Yixiang Shi,Marc Bissonnette,Chuan He,Wei Zhang,Jia Fan,Jianmin Xu

DOI: https://doi.org/10.1158/1078-0432.26422961.v1

2024-01-01

Abstract:Participant characteristics of 80 patients with other cancers.
Supplementary Figures 1-2, Tables 1-8 from Distinct Genomic Alterations in Prostate Cancers in Chinese and Western Populations Suggest Alternative Pathways of Prostate Carcinogenesis

Xueying Mao,Yongwei Yu,Lara K. Boyd,Guoping Ren,Dongmei Lin,Tracy Chaplin,Sakunthala C. Kudahetti,Elzbieta Stankiewicz,Liyan Xue,Luis Beltran,Manu Gupta,R. Tim D. Oliver,Nick R. Lemoine,Daniel M. Berney,Bryan D. Young,Yong-Jie Lu

DOI: https://doi.org/10.1158/0008-5472.22383381.v1

2023-01-01

Abstract:Supplementary Figures 1-2, Tables 1-8 from Distinct Genomic Alterations in Prostate Cancers in Chinese and Western Populations Suggest Alternative Pathways of Prostate Carcinogenesis
Supplementary Table S4 from A 5-Hydroxymethylcytosine-Based Noninvasive Model for Early Detection of Colorectal Carcinomas and Advanced Adenomas: The METHOD-2 Study

Wenju Chang,Zhou Zhang,Baoqing Jia,Kefeng Ding,Zhizhong Pan,Guoqiang Su,Wei Zhang,Tianyu Liu,Yunshi Zhong,Guodong He,Li Ren,Ye Wei,Dongdong Li,Xiaolong Cui,Jun Yang,Yixiang Shi,Marc Bissonnette,Chuan He,Wei Zhang,Jia Fan,Jianmin Xu

DOI: https://doi.org/10.1158/1078-0432.26422958.v1

2024-01-01

Abstract:Differetially modified gene bodies between CRC/AA and controls.
A Prognostic Analysis of 895 Cases of Stage III Colon Cancer in Different Colon Subsites

Yan Zhang,Junli Ma,Sai Zhang,Ganlu Deng,Xiaoling Wu,Jingxuan He,Haiping Pei,Hong Shen,Shan Zeng

DOI: https://doi.org/10.1007/s00384-015-2273-z

IF: 2.8

2015-01-01

International Journal of Colorectal Disease

Abstract:Stage III colon cancer is currently treated as an entity with a unified therapeutic principle. The aim of the retrospective study is to explore the clinicopathological characteristics and outcomes of site-specific stage III colon cancers and the influences of tumor location on prognosis.
Supplementary Tables 1-5 from Comprehensive Proteogenomic Profiling Reveals the Molecular Characteristics of Colorectal Cancer at Distinct Stages of Progression

Lingling Li,Dongxian Jiang,Hui Liu,Chunmei Guo,Qiao Zhang,Xuedong Li,Xiaojian Chen,Zheqi Chen,Jinwen Feng,Subei Tan,Wen Huang,Jie Huang,Chen Xu,Chen-Ying Liu,Wei Yu,Yingyong Hou,Chen Ding

DOI: https://doi.org/10.1158/0008-5472.26934664.v1

2024-01-01

Abstract:Supplementary tables of the revised manuscript.
Supplementary Table 1 from Distinct Subtypes of Gastric Cancer Defined by Molecular Characterization Include Novel Mutational Signatures with Prognostic Capability

Xiangchun Li,William K.K. Wu,Rui Xing,Sunny H. Wong,Yuexin Liu,Xiaodong Fang,Yanlin Zhang,Mengyao Wang,Jiaqian Wang,Lin Li,Yong Zhou,Senwei Tang,Shaoliang Peng,Kunlong Qiu,Longyun Chen,Kexin Chen,Huanming Yang,Wei Zhang,Matthew T.V. Chan,Youyong Lu,Joseph J.Y. Sung,Jun Yu

DOI: https://doi.org/10.1158/0008-5472.22410795.v1

2023-01-01

Abstract:Supplementary Table 1: Published publications and cohorts
Supplementary Tables 1-2, Figures 1-2 from Distinctive MicroRNA Profiles Relating to Patient Survival in Esophageal Squamous Cell Carcinoma

Yong Guo,Zhaoli Chen,Liang Zhang,Fang Zhou,Susheng Shi,Xiaoli Feng,Baozhong Li,Xin Meng,Xi Ma,Mingyong Luo,Kang Shao,Ning Li,Bin Qiu,Keith Mitchelson,Jing Cheng,Jie He

DOI: https://doi.org/10.1158/0008-5472.22371494

2023-01-01

Abstract:Supplementary Tables 1-2, Figures 1-2 from Distinctive MicroRNA Profiles Relating to Patient Survival in Esophageal Squamous Cell Carcinoma
Supplementary Tables 1 - 3 from Pathway-Based Serum microRNA Profiling and Survival in Patients with Advanced Stage Non–Small Cell Lung Cancer

Yan Wang,Jian Gu,Jack A. Roth,Michelle A.T. Hildebrandt,Scott M. Lippman,Yuanqing Ye,John D. Minna,Xifeng Wu

DOI: https://doi.org/10.1158/0008-5472.22396955

2023-01-01

Abstract:PDF file - 97K, Supplementary Table S1 summarized numbers of miRNA binding sites in TGF-beta pathway-related genes; Supplementary Table S2 showed raw Ct values and normalized expression levels of 35 miRNAs for qRT-PCR assays in 383 serum samples from the NSCLC study population recruited at the University of Texas MD Anderson Cancer Center between 2002 and 2009; Supplementary Table S3 showed differentially expressed serum miRNAs between Stage III and Stage IV groups for NSCLC study population recruited at the University of Texas MD Anderson Cancer Center between 2002 and 2009.
Table TS1 from Detection of MET Polysomy by Next-generation Sequencing and Its Clinical Relevance for MET Inhibitors

Boyang Sun,Tian Qiu,Xiaoling Zeng,Jianchun Duan,Hua Bai,Jiachen Xu,Jin Li,Junling Li,Xuezhi Hao,Yutao Liu,Lin,Hongyu Wang,Xin Zhang,Jia Zhong,Jie Wang,Jianming Ying,Zhijie Wang

DOI: https://doi.org/10.1158/2767-9764.22551552.v1

2023-01-01

Abstract:Clinicopathologic characteristics of patients in cohort 3.
Supplementary Table 2 from Identification and Validation of a Blood-Based 18-Gene Expression Signature in Colorectal Cancer

Xu Ye,Q. H. Xu,Li Yang,Xun Ye,Fang Liu,Fei Wu,Shujuan Ni,Cong Tan,Guoxiang Cai,Xiangjian Meng,Sanjun Cai,Xiuli Du

DOI: https://doi.org/10.1158/1078-0432.22452639.v1

2023-01-01

Abstract:PDF file - 70K, Signature genes enriched in Gene Ontology and KEGG pathway.
Additional File 1: of SMAD4 and NF1 Mutations As Potential Biomarkers for Poor Prognosis to Cetuximab-Based Therapy in Chinese Metastatic Colorectal Cancer Patients

Mingqing Zhu,Yang Shao,Peinan Lin,Xiaoxiao Cai,Biao Wang,Yan Ding,Xiongfeng Ma,Xue Wang,Yewei Xia,Dongqin Zhu,Yongqian Shu,Zan Fu,Yanhong Gu

DOI: https://doi.org/10.6084/m9.figshare.6197309

2018-01-01

Abstract:Table S1. Clinical characteristics of the 33 Chinese mCRC patients enrolled in this study. (XLSX 12 kb)
Supplementary Figure 3 from Comprehensive Proteogenomic Profiling Reveals the Molecular Characteristics of Colorectal Cancer at Distinct Stages of Progression

Lingling Li,Dongxian Jiang,Hui Liu,Chunmei Guo,Qiao Zhang,Xuedong Li,Xiaojian Chen,Zheqi Chen,Jinwen Feng,Subei Tan,Wen Huang,Jie Huang,Chen Xu,Chen-Ying Liu,Wei Yu,Yingyong Hou,Chen Ding

DOI: https://doi.org/10.1158/0008-5472.26934688

2024-01-01

Abstract:Supplementary Figure 3 and related legend of the revised manuscript.
Supplementary Table 3 from Ribonucleotide Reductase Small Subunit M2B Prognoses Better Survival in Colorectal Cancer

Xiyong Liu,Lily Lai,Xiaochen Wang,Lijun Xue,Sofia Leora,Jun Wu,Shuya Hu,Keqiang Zhang,Mei-Ling Kuo,Lun Zhou,Hang Zhang,Yafan Wang,Yan Wang,Bingsen Zhou,Rebecca A. Nelson,Shu Zheng,Suzhan Zhang,Peiguo Chu,Yun Yen

DOI: https://doi.org/10.1158/0008-5472.22393481

2023-01-01

Abstract:Supplementary Table 3 from Ribonucleotide Reductase Small Subunit M2B Prognoses Better Survival in Colorectal Cancer
Supplementary Figure A1 from Identification of Prognosis-Relevant Subgroups in Patients with Chemoresistant Triple-Negative Breast Cancer

Ke‐Da Yu,Rui Zhu,Mei Zhan,Angel Rodriguez,Wei Yang,Stephen T.C. Wong,Andreas Makris,Brian D. Lehmann,Xi Chen,Ingrid A. Mayer,Jennifer A. Pietenpol,Zhi‐Ming Shao,W. Fraser Symmans,Jenny Chang‐Claude

DOI: https://doi.org/10.1158/1078-0432.22446909

2023-01-01

Abstract:Supplementary Figure A1 PDF file 73K, Subgroup analysis of the extended validation cohort
Supplementary Figure 4 from Comprehensive Proteogenomic Profiling Reveals the Molecular Characteristics of Colorectal Cancer at Distinct Stages of Progression

Lingling Li,Dongxian Jiang,Hui Liu,Chunmei Guo,Qiao Zhang,Xuedong Li,Xiaojian Chen,Zheqi Chen,Jinwen Feng,Subei Tan,Wen Huang,Jie Huang,Chen Xu,Chen-Ying Liu,Wei Yu,Yingyong Hou,Chen Ding

DOI: https://doi.org/10.1158/0008-5472.26934685.v1

2024-01-01

Abstract:Supplementary Figure 4 and related legend of the revised manuscript.
Supplementary Table 4 from DNA Methylation-Mediated Repression of miR-886-3p Predicts Poor Outcome of Human Small Cell Lung Cancer

Jianzhong Cao,Yongmei Song,Nan Bi,Jie Shen,Wenyang Liu,Jing Fan,Guogui Sun,Tong Tong,Jie He,Yuankai Shi,Xun Zhang,Ning Lu,Yinghua He,Hongyu Zhang,Kelong Ma,Xiaoying Luo,Lei Lv,Hui Deng,Jing Cheng,Jingde Zhu,Luhua Wang,Qimin Zhan

DOI: https://doi.org/10.1158/0008-5472.22397195

2023-01-01

Abstract:PDF file - 40K, ECOG Performance Status.
Proteogenomic Characterization and Comprehensive Integrative Genomic Analysis of Human Colorectal Cancer Liver Metastasis

Yu-Shui Ma,Tao Huang,Xiao-Ming Zhong,Hong-Wei Zhang,Xian-Ling Cong,Hong Xu,Gai-Xia Lu,Fei Yu,Shao-Bo Xue,Zhong-Wei Lv,Da Fu

DOI: https://doi.org/10.1186/s12943-018-0890-1

IF: 37.3

2018-01-01

Molecular Cancer

Abstract:Background Proteogenomic characterization and integrative and comparative genomic analysis provide a functional context to annotate genomic abnormalities with prognostic value. Methods Here, we analyzed the proteomes and performed whole exome and transcriptome sequencing and single nucleotide polymorphism array profiling for 2 sets of triplet samples comprised of normal colorectal tissue, primary CRC tissue, and synchronous matched liver metastatic tissue. Results We identified 112 CNV-mRNA-protein correlated molecules, including up-regulated COL1A2 and BGN associated with prognosis, and four strongest hot spots (chromosomes X, 7, 16 and 1) driving global mRNA abundance variation in CRC liver metastasis. Two sites (DMRTB1 R202H and PARP4 V458I ) were revealed to frequent mutate only in the liver metastatic cohort and displayed dysregulated protein abundance. Moreover, we confirmed that the mutated peptide number has potential prognosis value and somatic variants displayed increased protein abundance, including high MYH9 and CCT6A expression, with clinical significance. Conclusions Our proteogenomic characterization and integrative and comparative genomic analysis provides a new paradigm for understanding human colon and rectal cancer liver metastasis. Trial registration ClinicalTrials, NCT02917707. Registered 28 September 2016, https://clinicaltrials.gov/ct2/show/NCT02917707 .

Supporting Table 3 from A Distinct Metabolic Signature of Human Colorectal Cancer with Prognostic Potential

Supporting Table 1 from A Distinct Metabolic Signature of Human Colorectal Cancer with Prognostic Potential

Supplementary Information from A Distinct Metabolic Signature of Human Colorectal Cancer with Prognostic Potential

Supporting Figure 2 from A Distinct Metabolic Signature of Human Colorectal Cancer with Prognostic Potential

Supplementary Table S3 from A 5-Hydroxymethylcytosine-Based Noninvasive Model for Early Detection of Colorectal Carcinomas and Advanced Adenomas: The METHOD-2 Study

Supplementary Figures 1-2, Tables 1-8 from Distinct Genomic Alterations in Prostate Cancers in Chinese and Western Populations Suggest Alternative Pathways of Prostate Carcinogenesis

Supplementary Table S4 from A 5-Hydroxymethylcytosine-Based Noninvasive Model for Early Detection of Colorectal Carcinomas and Advanced Adenomas: The METHOD-2 Study

A Prognostic Analysis of 895 Cases of Stage III Colon Cancer in Different Colon Subsites

Supplementary Tables 1-5 from Comprehensive Proteogenomic Profiling Reveals the Molecular Characteristics of Colorectal Cancer at Distinct Stages of Progression

Supplementary Table 1 from Distinct Subtypes of Gastric Cancer Defined by Molecular Characterization Include Novel Mutational Signatures with Prognostic Capability

Supplementary Tables 1-2, Figures 1-2 from Distinctive MicroRNA Profiles Relating to Patient Survival in Esophageal Squamous Cell Carcinoma

Supplementary Tables 1 - 3 from Pathway-Based Serum microRNA Profiling and Survival in Patients with Advanced Stage Non–Small Cell Lung Cancer

Table TS1 from Detection of MET Polysomy by Next-generation Sequencing and Its Clinical Relevance for MET Inhibitors

Supplementary Table 2 from Identification and Validation of a Blood-Based 18-Gene Expression Signature in Colorectal Cancer

Additional File 1: of SMAD4 and NF1 Mutations As Potential Biomarkers for Poor Prognosis to Cetuximab-Based Therapy in Chinese Metastatic Colorectal Cancer Patients

Supplementary Figure 3 from Comprehensive Proteogenomic Profiling Reveals the Molecular Characteristics of Colorectal Cancer at Distinct Stages of Progression

Supplementary Table 3 from Ribonucleotide Reductase Small Subunit M2B Prognoses Better Survival in Colorectal Cancer

Supplementary Figure A1 from Identification of Prognosis-Relevant Subgroups in Patients with Chemoresistant Triple-Negative Breast Cancer

Supplementary Figure 4 from Comprehensive Proteogenomic Profiling Reveals the Molecular Characteristics of Colorectal Cancer at Distinct Stages of Progression

Supplementary Table 4 from DNA Methylation-Mediated Repression of miR-886-3p Predicts Poor Outcome of Human Small Cell Lung Cancer

Proteogenomic Characterization and Comprehensive Integrative Genomic Analysis of Human Colorectal Cancer Liver Metastasis